市場調查報告書

全球薄膜層析法市場:成長,趨勢,及預測

Membrane Chromatography Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 922016
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
全球薄膜層析法市場:成長,趨勢,及預測 Membrane Chromatography Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 112 Pages
簡介

本報告提供全球薄膜層析法市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各產品·技術·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 生物醫藥品的需求增加
    • 加強了對精製流程清洗驗證的監管
    • 生物醫藥品產業上研究開發費的增加
  • 市場阻礙因素
    • 膜色譜產品在大規模生產中使用有限
  • 波特的五力分析

第5章 市場區隔

  • 各產品
    • 膠囊·濾芯
    • 針筒過濾器
    • 薄膜過濾器
    • 過濾器板
    • 旋轉管柱
    • 其他的消耗品·配件
  • 各技術
    • 離子交換膜色譜儀
    • 親和膜色譜
    • 疏水相互作用膜色譜(HIMC)
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • 3M
    • 旭化成株式會社
    • Cole-Parmer
    • Danaher Corporation
    • GE Healthcare
    • Membrane Solutions
    • Merck KGaA
    • Purilogics
    • Sartorius
    • Thermo Fisher Scientific

第7章 市場機會及今後趨勢

目錄
Product Code: 67477

Market Overview

Membrane chromatography is a well-established technology in bioprocessing that is routinely used in the capture of large particles such as viruses and viral vectors, and also in polishing steps for the removal of DNA, host cell protein impurities (HCP) and virus. There is an increasing demand for biopharmaceuticals and increasing regulatory scrutiny on the cleaning validation of downstream purification processes are the major factors for the growth of this market.

However, the limited use of membrane chromatography in large-scale manufacturing is expected to restrain the growth of this market during the forecast period.

Scope of the Report

Membrane chromatography is a technology in bioprocessing that is routinely used in the capture of large particles such as viruses and viral vectors, as well as in polishing steps for the removal of DNA, HCPs and virus.

In the report, a detailed analysis of the membrane chromatography market is provided. The market is evaluated by collating revenues generated across segments, categorized by product, technology, and geography.

Key Market Trends

Ion Exchange Membrane Chromatography is Expected to Cover a Large Share of the Market

Ion-exchange chromatography (IC) is a chromatography process that separates ions and polar molecules based on their affinity to the ion exchanger. It works on almost any kind of charged molecule, including large proteins, small nucleotides, and amino acids.

There has been a growing interest in the application of IC in the analysis of pharmaceutical drugs. IC is used in different aspects of product development and quality control testing. In one scuh example, IC is used to improve stabilities and solubility properties of pharmaceutical active drugs molecules as well as used to detect systems that have higher tolerance for organic solvents.IC is also widely used for detection and quantification of excipients or inactive ingredients used in pharmaceutical formulations.

The large share of this segment has been attributed to its wide applications in antibody polishing and virus purification due to the advantages associated with ion exchange membrane chromatography, such as scalability, robustness, disposable nature, high throughput, rapid processing, reduced buffer consumption, and a validation-free environment.

North America is Expected to Dominate the Membrane Chromatography Market

North America includes the United States (US), Canada and Mexico. The US and Canada have well structured and development healthcare systems. These countries also promote pharmaceutical research and development and hence have very high expenditure on healthcare. As a result of these policies, many companies globally are encouraged to operate in this region.

Many of the global pharmaceutical players have their headquarters and research labs in the US. As pharmaceutical research requires membrane chromatography, the demand for these technologies and processes is high is North America.This large share can be attributed to the increasing demand for biopharmaceuticals and rising R&D expenditure by biopharmaceutical companies in North America.

Competitive Landscape

The majority of the membrane chromatography technique and processe instruments are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Biopharmaceuticals
    • 4.2.2 Increasing Regulatory Scrutiny on the Cleaning Validation of Downstream Purification Processes
    • 4.2.3 Increasing R&D Expenditure in the Biopharmaceutical Industry
  • 4.3 Market Restraints
    • 4.3.1 Limited Use of Membrane Chromatography Products in Large-Scale Manufacturing
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Capsules & Cartridges
    • 5.1.2 Syringe Filters
    • 5.1.3 Membrane Filters
    • 5.1.4 Filter Plates
    • 5.1.5 Spin Columns
    • 5.1.6 Others Consumables and Accessories
  • 5.2 By Technique
    • 5.2.1 Ion Exchange Membrane Chromatography
    • 5.2.2 Affinity Membrane Chromatography
    • 5.2.3 Hydrophobic Interaction Membrane Chromatography (HIMC)
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Asahi Kasei
    • 6.1.3 Cole-Parmer
    • 6.1.4 Danaher Corporation
    • 6.1.5 GE Healthcare
    • 6.1.6 Membrane Solutions
    • 6.1.7 Merck KGaA
    • 6.1.8 Purilogics
    • 6.1.9 Sartorius
    • 6.1.10 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS